Bard Avaulta Mesh Side Effects

Transvaginal placement of Bard Avaulta surgical mesh, which is used to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI), has recently been linked to several serious Bard Avaulta side effects. According to a health alert issued by the FDA, the most frequently reported side effects associated with surgical mesh, including Bard Avaulta surgical mesh, include:

erosion through vaginal epithelium
infection
pain
urinary problems
recurrence of prolapse and/or incontinence

Other Bard Avaulta side effects may be caused during insertion of the

Dangerous Product Alerts

Bard Avaulta Transvaginal Mesh FDA Warning

Similar Defective Devices

Bard Avaulta mesh. These side effects may include bowel, bladder, and blood vessel perforation. In some cases, discomfort and pain (including dyspareunia) from vaginal scarring and surgical mesh erosion could lead to a significant decrease in patient quality of life. Treatment of the various types of side effects associated with transvaginal placement of Bard Avaulta mesh may require additional surgical procedures (some of them to remove the Bard Avaulta mesh), IV therapy, blood transfusions, and drainage of hematomas or abscesses.

Risk of Bard Avaulta Side Effects

The FDA has not yet determined whether specific characteristics put some patients at an increased risk for Bard Avaulta surgical mesh side effects. Factors contributing to Bard Avaulta side effects may include the patient’s overall health, the surgical mesh material, the size and shape of the Bard Avaulta mesh, the surgical technique used, concomitant procedures undertaken (e.g. hysterectomy), and possibly estrogen status.

In order to help the FDA learn more about possible side effects with transvaginal placement of surgical mesh, including Bard Avaulta mesh, physicians and patients are strongly encouraged to report side effects that may be associated with this medical device. Side effects related to Bard Avaulta mesh can be reported online, by mail, or by fax to the FDA’s MedWatch Adverse Event Reporting Program. The problems related to the Bard Avaulta surgical mesh, including mesh infections in particular, have led consumer advocates to call for a Bard Avaulta recall.